While the pathophysiology of diarrhea-predominant irritable bowel syndrome (IBS-D) is complex and heterogeneous, dysbiosis of the gut microbiome is frequently …

IBS (Irritable Bowel Syndrome)Diarrhea

~Estimated

~$10 – $6,250

Stanford UniversityNCT07238790

Phase 2

A Phase 2b, Randomized, Double-Blind, Placebo- Controlled, Multicenter Study to Assess the Safety, Efficacy and Pharmacokinetics of RNIB21 in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)

The purpose of this study is to examine the effectiveness of using a combination of a drug, rifaximin and a dietary supplement, N-acetyl-L-cysteine (NAC), to t…

IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)

~Estimated

~$10 – $7,500

Mark Pimentel, MDNCT06727422

Observational

Home-Based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Pain and Symptom Management Among Young Adults With Irritable Bowel Syndrome (IBS)

The goal of this clinical trial is to learn the feasibility and safety of using home-based taVNS in young adults with IBS to manage their IBS-related pain and …

Pain, ChronicIrritable Bowel SyndromeSymptom Cluster

~Estimated

~$10 – $6,250

Yale UniversityNCT06847360

← PreviousPage 4 of 4Next →